Reduced transplant arteriosclerosis in plasminogen-deficient mice

Journal of Clinical Investigation

Volumn 102, Issue 10, 1998, Pages 1788-1797

  Moons, Lieve ^a   Shi, Chengwei ^b   Ploplis, Victoria ^c   Plow, Edward ^c   Haber, Edgar ^b   Collen, Désiré ^a   Carmeliet, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Plasmin proteolysis; Transgenic mice; Transplant rejection; Transplantation

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; PLASMINOGEN; PLASMINOGEN ACTIVATOR; STROMELYSIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0032533903     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3316     Document Type: Article

References (33)

1. Balk, A.H.M.M. 1992. Chronic heart graft rejection in the clinical setting. In Organ Transplantation: Long Term Results. L.C. Paul and K. Solez, editors. Marcel Dekker Inc., New York. 187-196.
2. Paul, L.C. 1994. Functional and histologie characteristics of chronic renal allograft rejection. Clin. Transplant. 8:319-323.
3. Carmeliet, P., L. Moons, and D. Collen. 1998. Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis. Cardiovasc. Res. 39:8-33.
4. Russell, M.E., A.F. Wallace, W.W. Hancock, M.H. Sayegh, D.H. Adams, N.E. Sibinga, L.R. Wyner, and M.J. Karnovsky. 1995. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 59:572-578.
5. Libby, P. 1995. Molecular bases of the acute coronary syndromes. Circulation. 91:2844-2850.
6. Nagano, H., R.N. Mitchell, M.K. Taylor, S. Hasegawa, N.L. Tilney, and P. Libby. 1997. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 100:550-557.
7. Carmeliet, P., and D. Collen. 1996. Gene manipulation and transfer of the plasminogen and coagulation system in mice. Semin. Thromb. Hemost. 22: 525-542.
8. Dollery, C.M., J.R. McEwan, and A.M. Henney. 1995. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77:863-868.
9. Collen, D., and H.R. Lijnen. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:3114-3124.
10. Ploplis, V.A., E.L. French, P. Carmeliet, D. Collen, and E.F. Plow. 1998. Plasminogen deficiency differentially affects recruitment of inflammatory cell population in mice. Blood. 91:1-6.
11. Carmeliet, P., L. Moons, R. Lijnen, M. Baes, V. Lemaître, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu, and D. Collen. 1997. Urokinase-generated plasmin is a candidate activator of matrix metalloproteinases during atherosclerotic aneurysm formation. Nat. Genet. 17:439-444.
12. Lijnen, R., B. Van Hoef, F. Lupu, L. Moons, P. Carmeliet, and D. Collen. 1998. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler. Thromb. Vasc. Biol. 18:1035-1045.
13. Shi, C., M.E. Russell, C. Bianchi, J.B. Newell, and E. Haber. 1994. Murine model of accelerated transplant arteriosclerosis. Circ. Res. 75:199-207.
14. Ploplis, V.A., P. Carmeliet, S. Vazirzadeh, I. Van Vlaenderen, L. Moons, E.F. Plow, and D. Collen. 1995. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation. 92:2585-2593.
15. Carmeliet, P., L. Moons, J.M. Stassen, M. De Mol, A. Bouche, J.J. van den Oord, M. Kockx, and D. Collen. 1997. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am. J. Pathol. 150:761-776.
16. Carmeliet, P., L. Moons, J.-M. Herbert, J. Crawley, F. Lupu, R. Lijnen, and D. Collen. 1997. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81:829-839.
17. Carmeliet, P., L. Moons, R. Lijnen, S. Janssens, F. Lupu, D. Collen, and R.D.G. Gerard. 1997. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation. A gene targeting and a gene transfer study. Circulation. 96:3180-3191.
18. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J.J. van den Oord, D. Collen, and R.C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:419-424.
19. Carmeliet, P., L. Moons, V. Ploplis, E. Plow, and D. Collen. 1997. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J. Clin. Invest. 99:200-208.
20. Tsirka, S.E., T.H. Bugge, J.L. Degen, and S. Strickland. 1997. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc. Natl. Acad. Sci. USA. 94:9779-9781.
21. Russell, P.S., C.M. Chase, H.J. Winn, and R.B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J. Immunol. 152:5135-5141.
22. Russell, P.S., C.M. Chase, and R.B. Colvin. 1996. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am. J. Pathol. 149:91-99.
23. Shi, C., W.S. Lee, Q. He, D. Zhang, D.L. Fletcher, Jr., J.B. Newell, and E. Haber. 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sc. USA. 93:4051-4056.
24. Shi, C., W.S. Lee, M.E. Russell, D. Zhang, D.L. Fletcher, J.B. Newell, and E. Haber. 1997. Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice. Circulation. 96:2722-2728.
25. Saksela, O., and D.B. Rifkin. 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell. Biol. 4:93-126.
26. Ferrara, N., and T. Davis-Smyth. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25.
27. Munger, J.S., J.G. Harpel, P.E. Gleizes, R. Mazzieri, I. Nunes, and D.B. Rifkin. 1997. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. 51:1376-1382.
28. Behrendt, N., E. Ronne, and K. Dano. 1995. The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol. Chem. Hoppe Seyler. 376:269-279.
29. Chapman, H.A. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell. Biol. 9:714-724.
30. Bugge, T.H., K.W. Kombrinck, M.J. Flick, C.C. Daugherty, M.J. Danton, and J.L. Degen. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 87:709-719.
31. Isik, F.F., T.O. McDonald, M. Ferguson, E. Yamanaka, and D. Gordon. 1992. Transplant arteriosclerosis in a rat aortic model. Am. J. Pathol. 141:1139-1149.
32. Lang, R., M. Lustig, F. Francois, M. Sellinger, and H. Plesken. 1994. Apoptosis during macrophage-dependent ocular tissue remodelling. Development. 120:3395-3403.
33. Frisch, S.M., and E. Ruoslahti. 1997. Integrins and anoikis. Curr. Opin. Cell. Biol. 9:701-706.